What is the long-term trend for NuSkin Enterprises's number of derivative instruments held?

Over 4 years (2020 to 2024), NuSkin Enterprises's number of derivative instruments held has grown at a 0.0% compound annual growth rate (CAGR), from 4 to 4.

NuSkin Enterprises NUS Number of derivative instruments held

Number of derivative instruments held at other companies

RBK

Rhinebeck Bancorp, Inc.RBKB

42+75.0%

Citizens Financial Services, Inc.CZFS

5-16.7%

First Commonwealth FinancialFCF

2,000%-100pp

WSFS FinancialWSFS

107-26.2%

Kearny FinancialKRNY

1—

GCM Grosvenor Inc.GCMG

2—

Other financials

Income statement

See full

Revenue$320.6M-12.0%

Gross profit$214.5M-13.2%

Operating income$4.0M+141%

Net income$1.8M-98.3%

EPS (diluted)$0.04-98.1%

Balance sheet

See full

Cash & equivalents$198.7M-2.5%

Total debt$303.6M-8.2%

Total equity$794.1M+5.3%

Total assets$1.4B-1.1%

Cash flow

See full

Operating cash flow-$3.9M-1,107%

CapEx$13.7M+1.0%

Free cash flow-$17.6M-33.6%

Valuation

See full

Market cap$256.35M-38.2%

Where this comes from

Reported directly by NuSkin Enterprises in its filing.

Tagged under the XBRL concept us-gaap:DerivativeNumberOfInstrumentsHeld.

The official record: NuSkin Enterprises’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about NuSkin Enterprises's number of derivative instruments held.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NuSkin Enterprises's number of derivative instruments held?: NuSkin Enterprises (NUS) reported number of derivative instruments held of 4 in Q3 2025.
How has NuSkin Enterprises's number of derivative instruments held changed year-over-year?: NuSkin Enterprises's number of derivative instruments held decreased by 0.0% year-over-year, from 4 to 4.
What is the long-term trend for NuSkin Enterprises's number of derivative instruments held?: Over 4 years (2020 to 2024), NuSkin Enterprises's number of derivative instruments held has grown at a 0.0% compound annual growth rate (CAGR), from 4 to 4.